List of Figures:
Figure 5-1: US - Number of People Affected with Degenerative Diseases (Million), 1900 to 2050
Figure 5-2: Global - Regenerative Medicine Market (Billion US$), 2010-2014
Figure 5-3: Global - Regenerative Medicine Companies by Region (%)
Figure 5-4: Global - Tissue Engineered Products Market (Billion US$), 2010-2014
Figure 5-5: Global - Cell Therapy Market (Billion US$), 2010-2014
Figure 6-1: Global - Diabetes Prevalence in Developed and Developing Countries by Age Group (Million), 2010 & 2030
Figure 7-1: US - Regenerative Medicine Market (Billion US$), 2010-2014
Figure 7-2: US - CIRM Funding by Disease (%)
Figure 7-3: Europe - Regenerative Medicine Market (Billion US$), 2010-2014
Figure 7-4: Europe - Regenerative Medicine Companies by Segment (%)
Figure 7-5: Europe - Regenerative Medicine Companies by Country (%)
Figure 7-6: Europe - Share of Disease in Autologous Cellular Therapy (2009)
Figure 7-7: Europe - Share of Disease in Allogeneic Cellular Therapy (2009)
Figure 8-1: Global - Number of Patent Families for Regenerative Medicine by Country (1991-2011)
List of Tables:
Table 4-1: Global - R&D Spending by Key Players (Million US$), 2010
Table 4-2: Global - Number of People Aged above 60 Years in Key Countries (Million), 2009
Table 6-1: Stem Cell Characteristics for Cardiac Repair
Table 7-1: US - Potential Patient Population for Cell based Therapies (Million)
Table 7-2: US - Number of Patients Waiting for Organ Transplant
Table 7-3: India - List of Stem Cell Related Projects Funded by Department of Biotechnology
Table 9-1: Bioheart, Inc. - Products under Development
Table 9-2: Geron Corporation - Products under Development
